Pay in 4 interest-free payments of $143.12 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
InChi: InChI=1S/C11H14ClNO3/c1-8-7-9(12)4-5-10(8)16-6-2-3-11(14)13-15/h4-5
It inhibits the interaction between β-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of β-catenin/Tcf4 binding (Ki = 53
Daily exposure of PD-166866 to L6 cells at concentrations from 1 to 100 nM results in a concentration-related inhibition of bFGF-stimulated cell growth for 8 consecutive days with an IC50 value of 24 nM
PubMed PMID: 17975008
Chemical Name: N1-((4-(4-isopropoxyphenyl)-1H-pyrrol-3-yl)methyl)-N1-methylethane-1
BCX 4430 Size:Solid 10 mg InChi: InChI=1S/C11H14ClNO3/c1-8-7-9(12)4-5-10(8)16-6-2-3-11(14)13-15/h4-5Galidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,